Atlas Trials

Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer

Clinical trial NCT05529615 · RECRUITING

Trial details

NCT number
NCT05529615
Sponsor
Peking University Cancer Hospital & Institute
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Colon CancerCirculating Tumor DNA
Start date
2022-11-01
Primary completion
2029-05-01
Enrollment
2684

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.